Gamma-radiation-induced ATM-dependent signalling in human T-lymphocyte leukemic cells, MOLT-4

Acta Biochimica Polonica

Volumn 54, Issue 2, 2007, Pages 281-287

  Tichý, Aleš ^a,b   Záškodová, Darina ^b   Řezáčová, Martina ^b   Vávrová, Jiřina ^a   Vokurková, Doris ^c   Pejchal, Jaroslav ^a   Vilasová, Zdena ^a   Cerman, Jaroslav ^b   Österreicher, Jan ^a  

^a UNIVERSITY OF DEFENCE   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

^c UNIVERSITY HOSPITAL HRADEC KRALOVE   (Czech Republic)

Author keywords

ATM kinase; Checkpoint kinase 2; Ionizing radiation; Mdm2; p53

Indexed keywords

EID: 34447323874     PISSN: 0001527X     EISSN: 1734154X     Source Type: Journal    
DOI: 10.18388/abp.2007_3248     Document Type: Article

References (36)

1. Bao S, Tibbetts RS, Brumbaugh KM, Fang Y, Richardson DA, Ali A, Chen SM, Abraham RT, Wang XF (2001) ATR/ATM-mediated phosphorylation of human Rad17 is required for genotoxic stress responses. Nature 411: 969-974.
2. Bakkenist C, Kastan MB (2003) DNA damage activates ATM through intermolecular autophosphorylation and dimmer dissociation. Nature 421: 499-506.
3. Bekker-Jensen S, Lukas C, Kitagawa R, Melander F, Kastan MB, Bartek J, Lukas J (2006) Spatial organization of the mammalian genome surveillance machinery in response to DNA strand breaks. J Cell Biol 173: 195-206.
4. Canman CE, Lim DS, Cimprich KA, Taya Y, Tamai K, Sakaguchi K, Appella E, Kastan MB, Siliciano JD (1998) Activation of the ATM kinase by ionizing radiation and phosphorylation of p53. Science 281: 1677-1679.
5. Clarke AR, Purdie CA, Harrison DJ, Morris RG, Bird CC, Hooper ML, Wyllie AH (1993) Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature 6423: 849-852.
6. Claudio PP, Cui J, Ghafouri M, Mariano C, White MK, Safak M, Sheffield JB, Giordano A, Khalili K, Amini S, Sawaya BE (2006) Cdk9 phosphorylates p53 on serine 392 independently of CKII. J Cell Physiol 208: 602-612.
7. Criswell T, Leskov K, Miyamoto S, Luo G, Boothman DA (2003) Transcription factors activated in mammalian cells after clinically relevant doses of ionizing radiation. Oncogene 22: 5813-5827.
8. Endlich B, Radford IR, Forrester HB, Dewey WC (2000) Computerized video time-lapse microscopy studies of ionizing radiation-induced rapid-interphase and mitosis-related apoptosis in lymphoid cells. Radiat Res 1: 36-48.
9. Greenberg JM, Gonzalez-Sarmiento R, Arthur DC, Wilkowski CW, Streifel BJ, Kersey JH (1988) Immunophenotypic and cytogenetic analysis of Molt-3 and Molt-4: human T-lymphoid cell lines with rearrangement of chromosome 7. Blood 5: 1755-1760.
10. Helt CE, Cliby WA, Keng PC, Bambara RA, O'Reilly MA (2005) Ataxia telangiectasia mutated (ATM) and ATM and Rad3-related protein exhibit selective target specificities in response to different forms of DNA damage. J Biol Chem 280: 1186-1192.
11. Honda R, Tanaka H, Yasuda H (1997) Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53. FEBS Lett 420: 25-27.
12. Kaneko YS, Watanabe N, Morisaki H, Akita H, Fujimoto A, Tominaga K, Terasawa M, Tachibana A, Ikeda K, Nakanishi M (1999) Cell-cycle-dependent and ATM-in-dependent expression of human Chk1 kinase. Oncogene 18: 3673-3681.
13. Khanna KK, Lavin MF, Jackson SP, Mulhern TD (2001) ATM, a central controller of cellular responses to DNA damage. Cell Death Diff 8: 1052-1065.
14. Khosravi R, Maya R, Gottlieb T, Oren M, Shiloh Y, Shkedy D (1999) Rapid ATM-dependent phosphorylation of MDM2 precedes p53 accumulation in response to DNA damage. Proc Natl Acad Sci USA 96: 14973-14977.
15. Kim ST, Lim DS, Canman, CE, Kastan MB (1999) Substrate specificities and identification of putative substrates of ATM kinase family members. J Biol Chem 274: 37538-37543.
16. Lavin MF, Shiloh Y (1997) The genetic defect in ataxia-telangiectasia. Annu Rev Immunol 15:177-202.
17. Lavin MF, Khanna KK, Beamish H, Spring K, Watters D, Shiloh Y (1995) Relationship of the ataxia-telangiectasia protein ATM to phosphoinositide 3-kinase. Trends Bioch Sci 20: 382-383.
18. Ljungman M (2000) Dial 9-1-1 for p53: mechanisms of p53 activation by cellular stress. Neoplasia 2: 208-225.
19. Lim DS, Kim ST, Xu B, Maser RS, Lin J, Petrini JH, Kastan MB (2000) ATM phosphorylates p95/nbs1 in an S-phase checkpoint pathway. Nature 404: 613-617.
20. Lukas C, Bartkova J, Latella L, Falck J, Mailand N, Schroeder T, Sehested M, Lukas J, Bartek J (2001) DNA damage-activated kinase Chk2 is independent of proliferation or differentiation yet correlates with tissue biology. Cancer Res 61: 4990-4993.
21. Matsuoka S, Rotman G, Ogawa A, Shiloh Y, Tamai K, Elledge SJ (2000) Ataxia telangiectasia-mutated phosphorylates Chk2 in vivo and in vitro. Proc Natl Acad Sci USA 97: 10389-10394.
22. Maya R, Balass M, Kim ST, Shkedy D, Leal JF, Shifman O, Moas M, Buschmann T, Ronai Z, Shiloh Y, Kastan MB, Katzir E, Oren M (2001) ATM-dependent phosphorylation of Mdm2 on serine 395: Role in p53 activation by DNA damage. Genes Dev 15: 1067-1077.
23. Mukherjee B, Kessinger C, Kobayashi J, Chen BP, Chen DJ, Chatterjee A, Burma S (2006) DNA-PK phosphorylates histone H2AX during apoptotic DNA fragmentation in mammalian cells. DNA Repair 5: 575-590.
24. Nakano H, Shinohara K (1999) Correlation between unirradiated cell TP53 protein levels and radiosensitivity in MOLT-4 cells. Radiat Res 151: 686-693.
25. Nakano H, Kohara M, Shinohara K (2001) Evaluation of the relative contribution of p53-mediated pathway in X-ray-induced apoptosis in human leukemic MOLT-4 cells by transfection with a mutant p53 gene at different expression levels. Cell Tissue Res 306: 101-106.
26. Powers JT, Hong S, Mayhew CN, Rogers PM, Knudsen ES, Johnson DG (2004) E2F1 uses the ATM signaling pathway to induce p53 and Chk2 phosphorylation and apoptosis. Mol Cancer Res 4: 203-214.
27. Sakaguchi K, Sakamoto H, Lewis MS, Anderson CW, Erickson JW, Appella E, Xie D (1997) Phosphorylation of serine 392 stabilizes the tetramer formation of tumor suppressor protein p53. Biochemistry 36: 10117-10124.
28. Stiff T, Walker SA, Cerosaletti K, Goodarzi AA, Petermann E, Concannon P, O'driscoll M, Jeggo PA (2006) ATRdependent phosphorylation and activation of ATM in response to UV treatment or replication fork stalling. EMBO J 25: 5775-5782.
29. Szkanderova S, Vavrova J, Rezacova M, Vokurkova D, Pavlova S, Smardova J, Stulik J (2003) Gamma irradiation results in phosphorylation of p53 at serine-392 in human T-lymphocyte leukaemia cell line MOLT-4. Folia Biol (Prague) 49: 191-196.
30. Taniguchi T, Garcia-Higuera I, Xu B, Andreassen PR, Gregory RC, Kim ST, Lane WS, Kastan MB, D'Andrea AD (2002) Convergence of the Fanconi anemia and Ataxia telangiectasia signaling pathways. Cell 109: 459-472.
31. Vavrova J, Rezacova M, Vokurkova D, Psutka J (2004) Cell cycle alteration, apoptosis and response of leukemic cell lines to gamma radiation with high- and low-dose rate. Physiol Res 53: 335-342.
32. Yazdi PT, Wang Y, Zhao S, Patel N, Lee EY, Qin J (2002) SMC1 is a downstream effector in the ATM/NBS1 branch of the human S-phase checkpoint. Genes Dev 16: 571-582.
33. Xiao Z, Xue J, Sowin TJ, Zhang H (2006) Differential roles of checkpoint kinase 1, checkpoint kinase 2, and mitogen-activated protein kinase-activated protein kinase 2 in mediating DNA damage-induced cell cycle arrest: implications for cancer therapy. Mol Cancer Ther 8: 1935-1943.
34. Xu B, Kim ST, Kastan MB (2001) Involvement of Brca1 in S-phase and G2-phase checkpoints after ionizing irradiation. Mol Cell Biol 21: 3445-3450.
35. Xu B, O'Donnell AM, Kim ST, Kastan MB (2002) Phosphorylation of serine 1387 in Brca1 is specifically required for the Atm-mediated S-phase checkpoint after ionizing irradiation. Cancer Res 62: 4588-4591.
36. Zhao H, Watkins JL, Piwnica-Worms H (2002) Disruption of the checkpoint kinase 1/cell division cycle 25A pathway abrogates ionizing radiation-induced S and G2 checkpoints. Proc Natl Acad Sci USA 99: 14795-14800.